In Florida, California, and Illinois, researchers from several universities have found that two molecules in the immune system are crucial to drug resistance in breast cancers. Most breast cancer tumors are compelled by estrogen and drug treatments often include estrogen suppression, but unfortunately about half of patients don’t respond to those treatments. However, now that researchers know that two molecules, called interleukin 1 beta and tumor necrosis factor alpha, are responsible for the drug resistance in patients, it offers researchers key insights. Researchers hope to use the information and genomic, cellular and biochemical approaches to develop new treatments to block the resistance process for breast cancer patients.
Latest article
Mercedes-Benz taps Modern Meadow for 80% plant-based leather
In Germany, luxury car manufacturer Mercedes-Benz has partnered with New Jersey biodesign firm Moden Meadow to develop a next-generation leather alternative for its CONCEPT...
Bioluminescent dress from van Herpen portends era of living couture
In France, Dutch fashion designer Iris van Herpen has unveiled a dress embedded with 125 million bioluminescent algae at Paris Haute Couture Week 2025....
Stella McCartney’s latest sneaker can be composted, smells of cinnamon
In London, sustainable fashion pioneer Stella McCartney has unveiled a new version of its S-Wave sneakers, featuring soles made entirely from BioCir Flex, a...